SynSmart

Navi Mumbai, India Founded: 2014 • Age: 12 yrs
Provides chemistry services for research and scale-up projects.

About SynSmart

SynSmart is a Healthcare company based in Navi Mumbai (India) founded in 2014. It provides chemistry services for research and scale-up projects. It operates on a B2B model in Healthcare and Chemicals & Materials sectors. Its Indian entity Synsmart Rasayan Research Private Limited reported revenue of β‚Ή9.93 Cr. SynSmart offers products and services including Computational Chemistry Service, Medicinal Chemistry, Synthetic Chemistry, Process Research and Scale-Up, and ADME-PK Services. Its focus areas include Health and Life Sciences, Biotechnology, Drug Discovery and Synthetic Chemistry. Its competitors include Sai Life Sciences, Acies Bio, Personal Chemistry, NFIL and IRBM and 3 more; 2 of its 8 listed competitors have raised funding.

Company details

SynSmart offers computational, medicinal, synthetic chemistry, and process research services for early-stage discovery and manufacturing. The company supports global customers with a team of 100 chemists, handling projects from milligrams to multi-tonne scales. Based in India and the USA, it focuses on collaborative solutions in pharmaceuticals and biotechnology, ensuring high-quality results through expert leadership.

  • Headquarters Navi Mumbai, India
  • Sectors
    Healthcare
    Chemicals & Materials
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website synsmart.in
  • Social LinkedIn
  • Legal Name Synsmart Rasayan Research Private Limited
  • Date of Incorporation 04 Aug, 2014
  • Jurisdiction Navi Mumbai, Maharashtra, India
Key Metrics
  • Annual Revenue
    ₹9.93 Cr

    FY 2025 · +13% YoY

  • Net Loss
    -₹20.9 Lakh

    FY 2025 · -2% margin

  • EBITDA
    ₹1.24 Cr

    FY 2025 · 12% margin

Products & Services of SynSmart

SynSmart offers a comprehensive portfolio of products and services, including Computational Chemistry Service, Medicinal Chemistry, Synthetic Chemistry, Process Research and Scale-Up, and ADME-PK Services.

Computational Chemistry Service
Research Service

Offers computational modeling for chemical analysis.

Medicinal Chemistry
Drug Development

Provides synthesis for pharmaceutical compounds.

Synthetic Chemistry
Chemical Synthesis

Delivers custom synthesis for various applications.

Process Research and Scale-Up
Manufacturing Service

Supports scaling from lab to production levels.

ADME-PK Services
Pharmacokinetics

Analyzes drug absorption and metabolism processes.

Board of directors of Synsmart Rasayan Research Private Limited (SynSmart)

Synsmart Rasayan Research Private Limited is the primary company behind SynSmart. The board of Synsmart Rasayan Research Private Limited currently have 2 directors; the longest-serving is Sachin Suresh Narkhede, appointed in 2014. 4 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Sachin Suresh Narkhede
DIN 06872463
Director04 Aug 201412 yrs 2 moSynsmart Rasayan Research Private Limited
Neeta Chetan Mahajan
DIN 11086871
Additional Director02 May 20251 yr 5 moSynsmart Rasayan Research Private Limited

Financials of SynSmart

Figures of Synsmart Rasayan Research Private Limited, the primary company behind SynSmart, for FY 2025. Revenue was ₹9.93 Cr (+13% year on year). Net loss was -₹20.9 Lakh (-2% margin). EBITDA was ₹1.24 Cr (12% margin). Revenue has grown at a compounded annual rate of +69% over three years and +48% over five years.

  • ₹9.93 CrRevenue · FY 2025 · +13% YoY
  • -₹20.9 LakhNet loss · -2% margin
  • ₹1.24 CrEBITDA · 12% margin
  • ₹1.2 LakhPaid-up capital
  • 79Employees (provident fund records)
  • +69%Revenue CAGR, 3 years
  • +48%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Synsmart Rasayan Research Private Limited are on its company page.

Premium access

Detailed financial statements for SynSmart

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Competitors of SynSmart

SynSmart has 8 listed competitors in our database, 2 of them funded. They include Sai Life Sciences, Acies Bio, Personal Chemistry, NFIL and IRBM, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
sailife.com1999Hyderabad, India$112.18M2,948
Complex small molecules are discovered, developed, and manufactured for pharmaceuticals.
aciesbio.com2006Ljubljana, Slovenia––
Provider of drug discovery and development services to pharmaceutical, biotech, and food industries
personalchemistry.com1998Uppsala, Sweden$50.46M–
Coherent Synthesis is developed for medicinal and combinatorial chemistry applications.
nfil.in1967Mumbai, India–1,476
Fluorinated compounds are synthesized and manufactured customly for various industries.
irbm.com2010Pomezia, Italy––
Integrated drug discovery and preclinical development services are provided.
medicilon.com2004Pudong, China––
Integrated drug discovery and preclinical services are provided.
bioduro.com2005San Diego, United States––
Integrated drug discovery and development services
spirochem.com2011Zurich, Switzerland––
Swiss fine chemicals company providing API, Intermediates and custom synthesis services for the pharma and biotech industry
Premium access

Detailed competitors of SynSmart

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Clinical Trials & Research Tech

10 companies that operate in the same segment as SynSmart (Clinical Trials & Research Tech), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Genetic services are provided by Colossal's laboratory operations.
2021Austin, Texas, United StatesUSD 617.6 M–252
Research lab engaged in pharmacological measurements on therapeutic protein variants
2018United StatesUSD 78.19 M–22
Drug development services encompassing clinical trials, bioanalytical support, and real-world evidence in healthcare.
2004Ahmedabad, Gujarat, India–USD 50.52 M902
Generic injectables for oncology and anesthesiology are manufactured.
1989Hyderabad, Telangana, India–USD 4.22 M228
Medical research labs are provided by GALY for scientific purposes.
2018Boston, Massachusetts, United StatesUSD 61.59 M–25
Laboratory focused on biotechnology & molecule research services
2018Cambridge, Massachusetts, United StatesUSD 32.68 M––
Laboratory delivers discovery & research in nuclear and particle physics
1947United States––2,436
Research and manufacturing of hemp products are conducted by BRC.
2017Monterey, California, United StatesUSD 25.26 M–16
Genome sequencing studies are conducted for medical research purposes.
2020Cambridge, Cambridgeshire, United KingdomUSD 11.26 M–12
Novel immunotherapy therapeutic targets are discovered through laboratory research.
2019Branford, Connecticut, United StatesUSD 92 M––
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about SynSmart

SynSmart was founded in 2014.

SynSmart is headquartered in Navi Mumbai, India. It is registered at Navi Mumbai, Maharashtra, India.

The primary company behind SynSmart, Synsmart Rasayan Research Private Limited, reported revenue of β‚Ή9.93 Cr for FY 2025, up 13% year on year.

SynSmart offers computational, medicinal, synthetic chemistry, and process research services for early-stage discovery and manufacturing. The company supports global customers with a team of 100 chemists, handling projects from milligrams to multi-tonne scales. Based in India and the USA, it focuses on collaborative solutions in pharmaceuticals and biotechnology, ensuring high-quality results through expert leadership.

SynSmart's top competitors include Sai Life Sciences, Acies Bio and Medicilon.

SynSmart offers Computational Chemistry Service, Medicinal Chemistry, Synthetic Chemistry, Process Research and Scale-Up, and ADME-PK Services.

SynSmart operates through Synsmart Rasayan Research Private Limited.

The legal entities of SynSmart currently have 2 directors, including Sachin Suresh Narkhede, Neeta Chetan Mahajan.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available